Testimonies from the Trenches Series - Low-Barrier Buprenorphine Treatment (On-Demand)-Testimonies from the Trenches Series

Testimonies from the Trenches Series - Low-Barrier Buprenorphine Treatment

Video Transcription

Video Summary

In this webinar, titled "Expanding Access to Opioid Use Disorder Care with Low Barrier Approaches," Dr. Shoshana Aronowitz discusses innovative delivery models to promote equitable access to substance use treatment and harm reduction services. She emphasizes the importance of low-barrier approaches in addressing common barriers to receiving opioid use disorder care, such as high threshold programs, distance to treatment centers, stigma, and cost issues. Dr. Aronowitz also highlights the effectiveness of buprenorphine and methadone in reducing overdose risk and explores strategies like same-day access to medication, flexible scheduling, harm reduction practices, telehealth, and mobile models to make care more accessible. She discusses the concepts of urine drug screening, microdosing for buprenorphine induction, and the role of pharmacists in dispending buprenorphine prescriptions. Overall, her presentation aims to increase comfort with providing opioid use disorder treatment to patients who have struggled to access care in traditional settings.

Keywords

Low Barrier Approaches

Equitable Access

Substance Use Treatment

Harm Reduction Services

Buprenorphine

Methadone